Lenzilumab (Anti-CSF2 / GM-CSF)
Lenzilumab (Anti-CSF2 / GM-CSF) is a recombinant monoclonal antibody against the cytokine granulocyte macrophage colony-stimulating factor (GM-CSF), with potential immunomodulating activity. MW: 145.72 KD.
| Trivial name | KB 003 |
| Catalog Number | A2854 |
| CAS# | 1229575-09-0 |
| Size | 1mg |